Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Enzyme-linked Receptors01:00

Enzyme-linked Receptors

64.6K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
64.6K
Amyloid Fibrils03:03

Amyloid Fibrils

10.2K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
10.2K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

35
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The Interplay of Splicing and Metabolism in Cancer.

Cells·2026
Same author

Self-clustering of three CBX2 molecules drives PRC2 to promote facultative heterochromatinization of Polycomb target genes.

Molecular cell·2026
Same author

Diagnostically competitive performance of a physiology-informed generative multi-task network for contrast-free CT perfusion.

Frontiers in human neuroscience·2026
Same author

Diagnostically Competitive Performance of a Physiology-Informed Generative Multi-Task Network for Contrast-Free CT Perfusion.

ArXiv·2026
Same author

ATP-Ion Complexation and Lithium's Bioactive Form in Cellular Solutions.

Journal of the American Chemical Society·2025
Same author

A mitochondrial surveillance mechanism activated by <i>SRSF2</i> mutations in hematologic malignancies.

bioRxiv : the preprint server for biology·2024

相关实验视频

Updated: May 5, 2026

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP
07:55

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP

Published on: October 17, 2015

10.7K

GSK-3alpha 调节了阿尔茨海默病中氨基酸β的产生.

Christopher J Phiel1, Christina A Wilson, Virginia M-Y Lee

  • 1Department of Medicine, Division of Hematology-Oncology and Howard Hughes Medical Institute, University of Pennsylvania School of Medicine, Philadelphia, Philadelphia 19104-6148, USA.

Nature
|May 23, 2003
PubMed
概括

是一种GSK-3抑制剂,通过阻断粉样蛋白前体蛋白 (APP) 的马分泌酶裂解来减少阿尔茨海默病模型中的粉样蛋白-β的产生. 这种双重作用针对的是粉样质斑块和团.

科学领域:

  • 神经科学是一个神经科学.
  • 生物化学 生物化学
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 阿尔茨海默病 (AD) 涉及粉样ββ (Abeta) 的产生和聚合.
  • 阿贝塔是由粉样蛋白前体蛋白 (APP) 通过BACE和玛分泌酶裂变生成的.
  • 普列尼林对玛分泌酶的功能至关重要,并与其他蛋白质相互作用.

研究的目的:

  • 为了研究,一种糖原合成酶激酶-3β (GSK-3β) 抑制剂,对阿贝塔生产的影响.
  • 要确定是否影响APP的玛分泌酶裂变.
  • 探索在减少AD病理特征方面的潜力.

主要方法:

  • 在阿尔茨海默病的细胞和小鼠模型中用治疗.
  • 评估阿贝塔的产生和APP裂变.
  • 在过度表达APP的小鼠中评估对Notch处理和Abeta积累的影响.
  • 识别所准的特定GSK-3异型.

主要成果:

  • 通过抑制在玛分泌酶阶段的APP裂变来阻止阿贝塔的产生.
  • 并没有抑制Notch处理.
  • 减少了APP过度表达小鼠的大脑中的阿贝塔积累.

更多相关视频

Quantitative Measurement of &#947;-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms
06:40

Quantitative Measurement of γ-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms

Published on: January 25, 2018

6.2K
Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by &#947;-Secretase
11:57

Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by γ-Secretase

Published on: June 24, 2025

733

相关实验视频

Last Updated: May 5, 2026

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP
07:55

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP

Published on: October 17, 2015

10.7K
Quantitative Measurement of &#947;-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms
06:40

Quantitative Measurement of γ-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms

Published on: January 25, 2018

6.2K
Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by &#947;-Secretase
11:57

Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by γ-Secretase

Published on: June 24, 2025

733
  • 的目标是GSK-3alpha,这对于最大APP处理至关重要.
  • 结论:

    • 对GSK-3alpha的抑制为阿尔茨海默病提供了一种新的治疗策略.
    • 准GSK-3alpha可能会减少粉样质斑块和神经纤维状结.
    • 对阿贝塔和病理的双重作用为AD治疗提供了一个有前途的途径.